331 related articles for article (PubMed ID: 33203119)
1. The Non-Coding Landscape of Cutaneous Malignant Melanoma: A Possible Route to Efficient Targeted Therapy.
Lazăr AD; Dinescu S; Costache M
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33203119
[TBL] [Abstract][Full Text] [Related]
2. Comparative Expression Profiling Reveals Molecular Markers Involved in the Progression of Cutaneous Melanoma towards Metastasis.
Lazăr AD; Dinescu S; Sleiman L; Dumitru AV; Costache M; Costache M
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047539
[TBL] [Abstract][Full Text] [Related]
3. The emerging role of long non-coding RNAs in cutaneous melanoma.
Leucci E; Coe EA; Marine JC; Vance KW
Pigment Cell Melanoma Res; 2016 Nov; 29(6):619-626. PubMed ID: 27606977
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNAs in cutaneous melanoma: clinical perspectives.
Hulstaert E; Brochez L; Volders PJ; Vandesompele J; Mestdagh P
Oncotarget; 2017 Jun; 8(26):43470-43480. PubMed ID: 28415644
[TBL] [Abstract][Full Text] [Related]
5. The Functional Role of Long Non-Coding RNAs in Melanoma.
Wozniak M; Czyz M
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638331
[TBL] [Abstract][Full Text] [Related]
6. Interplay between small and long non-coding RNAs in cutaneous melanoma: a complex jigsaw puzzle with missing pieces.
Riefolo M; Porcellini E; Dika E; Broseghini E; Ferracin M
Mol Oncol; 2019 Jan; 13(1):74-98. PubMed ID: 30499222
[TBL] [Abstract][Full Text] [Related]
7. Expression profiles analysis of long non-coding RNAs identified novel lncRNA biomarkers with predictive value in outcome of cutaneous melanoma.
Ma X; He Z; Li L; Yang D; Liu G
Oncotarget; 2017 Sep; 8(44):77761-77770. PubMed ID: 29100423
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
[TBL] [Abstract][Full Text] [Related]
9. Clinical protein science in translational medicine targeting malignant melanoma.
Gil J; Betancourt LH; Pla I; Sanchez A; Appelqvist R; Miliotis T; Kuras M; Oskolas H; Kim Y; Horvath Z; Eriksson J; Berge E; Burestedt E; Jönsson G; Baldetorp B; Ingvar C; Olsson H; Lundgren L; Horvatovich P; Murillo JR; Sugihara Y; Welinder C; Wieslander E; Lee B; Lindberg H; Pawłowski K; Kwon HJ; Doma V; Timar J; Karpati S; Szasz AM; Németh IB; Nishimura T; Corthals G; Rezeli M; Knudsen B; Malm J; Marko-Varga G
Cell Biol Toxicol; 2019 Aug; 35(4):293-332. PubMed ID: 30900145
[TBL] [Abstract][Full Text] [Related]
10. Deciphering the Molecular Landscape of Cutaneous Squamous Cell Carcinoma for Better Diagnosis and Treatment.
Lazar AD; Dinescu S; Costache M
J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32674318
[TBL] [Abstract][Full Text] [Related]
11. lncRNAs-EZH2 interaction as promising therapeutic target in cutaneous melanoma.
Wozniak M; Czyz M
Front Mol Biosci; 2023; 10():1170026. PubMed ID: 37325482
[TBL] [Abstract][Full Text] [Related]
12. Genetics and epigenetics of cutaneous malignant melanoma: a concert out of tune.
van den Hurk K; Niessen HE; Veeck J; van den Oord JJ; van Steensel MA; Zur Hausen A; van Engeland M; Winnepenninckx VJ
Biochim Biophys Acta; 2012 Aug; 1826(1):89-102. PubMed ID: 22503822
[TBL] [Abstract][Full Text] [Related]
13. A Review of Advanced Cutaneous Melanoma Therapies and Their Mechanisms, from Immunotherapies to Lysine Histone Methyl Transferase Inhibitors.
de Oliveira Filho RS; de Oliveira DA; Nisimoto MM; Marti LC
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136297
[TBL] [Abstract][Full Text] [Related]
14. The Emerging Therapeutic Landscape of Advanced Melanoma.
Henriques V; Martins T; Link W; Ferreira BI
Curr Pharm Des; 2018; 24(5):549-558. PubMed ID: 29366407
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA expression identified by microarray analysis: Candidate biomarkers in human acral lentiginous melanoma.
Shi HZ; Xiong JS; Xu CC; Bu WB; Wang Y; Sun JF; Chen H
Oncol Lett; 2020 Feb; 19(2):1465-1477. PubMed ID: 31966073
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers in melanoma.
Griewank KG
Scand J Clin Lab Invest Suppl; 2016; 245():S104-12. PubMed ID: 27467728
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs in the pathogenesis of malignant melanoma.
Glud M; Gniadecki R
J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):142-50. PubMed ID: 22621697
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-mediated regulation of melanoma.
Sun V; Zhou WB; Majid S; Kashani-Sabet M; Dar AA
Br J Dermatol; 2014 Aug; 171(2):234-41. PubMed ID: 24665835
[TBL] [Abstract][Full Text] [Related]
19. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.
Ascierto PA; Atkins M; Bifulco C; Botti G; Cochran A; Davies M; Demaria S; Dummer R; Ferrone S; Formenti S; Gajewski TF; Garbe C; Khleif S; Kiessling R; Lo R; Lorigan P; Arthur GM; Masucci G; Melero I; Mihm M; Palmieri G; Parmiani G; Puzanov I; Romero P; Schilling B; Seliger B; Stroncek D; Taube J; Tomei S; Zarour HM; Testori A; Wang E; Galon J; Ciliberto G; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2015 Nov; 13():374. PubMed ID: 26619946
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs in cancer: lessons from melanoma.
Greenberg E; Nemlich Y; Markel G
Curr Pharm Des; 2014; 20(33):5246-59. PubMed ID: 24479804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
